RealTalk MS10 Okt 2025

Special Episode: The Risks and Rewards of Participating in Clinical Trials with Dr. Kathy Zackowski and Mimi Brown

Welcome to a RealTalk MS special series on MS clinical trials. This special series is made possible through a generous grant from Sanofi. In today's episode, we're exploring the risks and rewards of participating in a clinical trial with Dr. Kathy Zackowski and Mimi Brown.

Dr. Zackowski is the Associate Vice President of Research at the National MS Society, and she's going to offer an overview of the risks and benefits that you'll want to weigh in considering participating in a clinical trial. Mimi Brown lives with primary progressive MS, and Mimi is going to share her own experience as a participant in multiple clinical trials.

This special episode of RealTalk MS has been made possible through a generous grant from Sanofi. Sanofi has two ongoing Phase 3 clinical trials in MS studying Frexalimab, an investigational second-generation anti-CD40 ligand monoclonal antibody. If you are interested in learning more about these clinical trials, please visit SanofiStudies.com

SHARE THIS EPISODE OF REALTALK MS

Just copy this link & paste it into your text or email: https://realtalkms.com/ct2

ADD YOUR VOICE TO THE CONVERSATION

I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!

Email: jon@realtalkms.com
Phone: (310) 526-2283

And don't forget to join us in the RealTalk MS Facebook group!

Privacy Policy

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(535)

Episode 481: It's Time to Update the Way We Describe MS with Dr. Peter Calabresi

The current clinical language used to describe multiple sclerosis hasn't kept pace with modern neuroscience—and clinging to outdated categories can stall treatment decisions, muddy research, and obscu...

9 Nov 31min

Episode 480: MSToronto 2026 with Dr. Jeffrey Cohen and Dr. Robert Fox

Our coverage of MSToronto 2026 continues this week with two important conversations. First, we'll hear from Dr. Jeffrey Cohen about the latest clinical findings on CAR-T cell therapy as a potential tr...

2 Nov 36min

Episode 479: From MSToronto 2026 with Dr. Bruce Bebo and Kristine Werner Ozug

Last week, about 8,000 MS researchers and clinicians arrived in Toronto, Canada, for MSToronto 2026, the joint meeting of the Americas Committee for Treatment and Research in MS and the European Commi...

29 Okt 45min

Episode 478: From MSToronto 2026 Patient Community Day with Professor Peter Feys and Karen Jacoby

Welcome to a special episode of RealTalk MS and The ECTRIMS Podcast! MS Toronto 2026 concluded with the event we were most looking forward to -- Patient Community Day -- where some of the top MS exper...

26 Okt 22min

Episode 477: One Year After CAR T-Cell Therapy with Jan Janisch-Hanzlik

Jan Janisch-Hanzlik was the first MS patient to receive CAR T-cell therapy as part of a clinical trial. We met Jan last year, in episode 424 of RealTalk MS, when she gave us a first-hand report on how...

19 Okt 30min

Episode 476: MS in the Workplace with Dana Foote

What happens when you're diagnosed with a chronic, unpredictable condition just as your career is taking off? That's exactly what happened to my guest, Dana Foote. This week, Dana joins us to sha...

12 Okt 36min

Episode 475: New Tools and Strategies for Managing MS-Related Cognitive Changes with Dr. Elizabeth Gromisch

Whether it's walking into a room and blanking on why you're there, struggling to pull up a word that's right on the tip of your tongue, or losing track of daily tasks, cognitive fatigue and brain fog ...

5 Okt 30min

Episode 474: The House That MS Built with Sarah Timmerman

Most people don't think about home accessibility until mobility changes force the conversation. But what if you decide to take control of the unknown and design your living space for whatever the futu...

28 Sep 25min